Skip to main content
JW LIFESCIENCE CORPORATION logo

JW LIFESCIENCE CORPORATION — Investor Relations & Filings

Ticker · 234080 ISIN · KR7234080000 KO Manufacturing
Open in API
Filings indexed 191 across all filing types
Latest filing 2021-01-28 Major Shareholding Noti…
Country KR South Korea
Listing KO 234080

About JW LIFESCIENCE CORPORATION

https://www.jw-lifescience.co.kr/lifesc…

JW LIFESCIENCE CORPORATION is a specialized manufacturer focused on the development and production of infusion solutions. The company's product portfolio includes a comprehensive range of intravenous (IV) fluids, from basic solutions to advanced nutrient infusions containing essential components such as amino acids, lipids, proteins, vitamins, and minerals. A key area of innovation is the development of high-value-added products, including multi-chambered infusion solutions. The company operates world-class manufacturing facilities and maintains dedicated research and development centers to support its commitment to producing high-quality medical fluids for patient treatment.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. This type of filing is specifically used to report changes in shareholdings by major shareholders (in this case, the National Pension Service) or insiders. In the context of global financial reporting, this falls under the category of 'Major Shareholding Notification' (MRQ) as it details the acquisition/disposal of shares by a 10% or greater shareholder.
2021-01-28 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on the Status of Large Shareholdings' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the acquisition of shares by Barings Asset Management in JW Life Science, crossing the 5% threshold. This type of filing is specifically categorized as a Major Shareholding Notification.
2021-01-26 Korean
타법인주식및출자증권양수결정
M&A Activity Classification · 100% confidence The document is a formal regulatory filing regarding the acquisition of shares in another company (JW Bioscience) by JW Life Science. It details the transaction terms, the purpose of the acquisition, financial data of the target company, and board approval details. This type of disclosure is a standard 'Material Matter Report' (주요사항보고서) in the Korean regulatory context, which falls under M&A activity and corporate restructuring. Given the provided categories, 'TAR' (M&A Activity) is the most accurate classification for a document announcing the acquisition of shares in another entity.
2020-12-18 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership (including specific transaction dates and methods like '장내매수'), and the relationship between the reporting entity (JW Holdings) and the issuer (JW Life Science). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-12-02 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for JW Life Science for the 3rd quarter of 2020. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which fits the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-16 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for JW Life Science, detailing quarterly financial highlights such as revenue, operating profit, and net income. It is a short, structured announcement of financial results rather than a full quarterly report or a report publication announcement. Therefore, it fits the definition of an Earnings Release (ER). 9M 2020
2020-11-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.